198 related articles for article (PubMed ID: 19935793)
1. Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine.
Overman MJ; Pozadzides J; Kopetz S; Wen S; Abbruzzese JL; Wolff RA; Wang H
Br J Cancer; 2010 Jan; 102(1):144-50. PubMed ID: 19935793
[TBL] [Abstract][Full Text] [Related]
2. Molecular profiling and identification of prognostic factors in Chinese patients with small bowel adenocarcinoma.
Pan H; Cheng H; Wang H; Ge W; Yuan M; Jiang S; Wan X; Dong Y; Liu Z; Zhao R; Fang Y; Lou F; Cao S; Han W
Cancer Sci; 2021 Nov; 112(11):4758-4771. PubMed ID: 34449929
[TBL] [Abstract][Full Text] [Related]
3. Prognostic relevance of programmed death-ligand 1 expression and microsatellite status in small bowel adenocarcinoma.
Klose J; Lasitschka F; Horsch C; Strowitzki MJ; Bruckner T; Volz C; Schmidt T; Schneider M
Scand J Gastroenterol; 2020 Mar; 55(3):321-329. PubMed ID: 32191146
[No Abstract] [Full Text] [Related]
4. Evaluation of PTEN and Mcl-1 expressions in NSCLC expressing wild-type or mutated EGFR.
Cetin Z; Ozbilim G; Erdogan A; Luleci G; Karauzum SB
Med Oncol; 2010 Sep; 27(3):853-60. PubMed ID: 19763916
[TBL] [Abstract][Full Text] [Related]
5. An insight into the genetic pathway of adenocarcinoma of the small intestine.
Wheeler JM; Warren BF; Mortensen NJ; Kim HC; Biddolph SC; Elia G; Beck NE; Williams GT; Shepherd NA; Bateman AC; Bodmer WF
Gut; 2002 Feb; 50(2):218-23. PubMed ID: 11788563
[TBL] [Abstract][Full Text] [Related]
6. Genomic Profiling of Small-Bowel Adenocarcinoma.
Schrock AB; Devoe CE; McWilliams R; Sun J; Aparicio T; Stephens PJ; Ross JS; Wilson R; Miller VA; Ali SM; Overman MJ
JAMA Oncol; 2017 Nov; 3(11):1546-1553. PubMed ID: 28617917
[TBL] [Abstract][Full Text] [Related]
7. ERBB2 gene as a potential therapeutic target in small bowel adenocarcinoma.
Laforest A; Aparicio T; Zaanan A; Silva FP; Didelot A; Desbeaux A; Le Corre D; Benhaim L; Pallier K; Aust D; Pistorius S; Blons H; Svrcek M; Laurent-Puig P
Eur J Cancer; 2014 Jul; 50(10):1740-1746. PubMed ID: 24797764
[TBL] [Abstract][Full Text] [Related]
8. Panel gene profiling of small bowel adenocarcinoma: Results from the NADEGE prospective cohort.
Aparicio T; Svrcek M; Henriques J; Afchain P; Lièvre A; Tougeron D; Gagniere J; Terrebonne E; Piessen G; Legoux JL; Lecaille C; Pocard M; Gornet JM; Zaanan A; Lavau-Denes S; Lecomte T; Deutsch D; Vernerey D; Puig PL
Int J Cancer; 2021 Apr; 148(7):1731-1742. PubMed ID: 33186471
[TBL] [Abstract][Full Text] [Related]
9. Large-scale N-terminal deletions but not point mutations stabilize beta-catenin in small bowel carcinomas, suggesting divergent molecular pathways of small and large intestinal carcinogenesis.
Breuhahn K; Singh S; Schirmacher P; Bläker H
J Pathol; 2008 Jul; 215(3):300-7. PubMed ID: 18491352
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of immunohistochemistry for mismatch repair protein and microsatellite instability examination in adenocarcinoma and background endometrium of sporadic endometrial cancer cases.
Saeki H; Hlaing MT; Horimoto Y; Kajino K; Ohtsuji N; Fujino K; Terao Y; Hino O
J Obstet Gynaecol Res; 2019 Oct; 45(10):2037-2042. PubMed ID: 31307113
[TBL] [Abstract][Full Text] [Related]
11. DNA mismatch repair deficiency in surgically resected lung adenocarcinoma: Microsatellite instability analysis using the Promega panel.
Takamochi K; Takahashi F; Suehara Y; Sato E; Kohsaka S; Hayashi T; Kitano S; Uneno T; Kojima S; Takeuchi K; Mano H; Suzuki K
Lung Cancer; 2017 Aug; 110():26-31. PubMed ID: 28676214
[TBL] [Abstract][Full Text] [Related]
12. DNA mismatch repair deficiency in breast carcinoma: a pilot study of triple-negative and non-triple-negative tumors.
Wen YH; Brogi E; Zeng Z; Akram M; Catalano J; Paty PB; Norton L; Shia J
Am J Surg Pathol; 2012 Nov; 36(11):1700-8. PubMed ID: 22992699
[TBL] [Abstract][Full Text] [Related]
13. Microsatellite instability and expression of MLH1 and MSH2 in carcinomas of the small intestine.
Planck M; Ericson K; Piotrowska Z; Halvarsson B; Rambech E; Nilbert M
Cancer; 2003 Mar; 97(6):1551-7. PubMed ID: 12627520
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor overexpression/amplification in adenocarcinomas arising in the gastrointestinal tract.
Rossi E; Villanacci V; Danesino C; Donato F; Nascimbeni R; Bassotti G
Rev Esp Enferm Dig; 2011 Dec; 103(12):632-9. PubMed ID: 22217347
[TBL] [Abstract][Full Text] [Related]
15. [Findings of genetic changes in small intestinal carcinomas].
Hirai A; Hibi K; Nakamura H; Fujikake Y; Matsui T; Kasai Y; Akiyama S; Ito K; Takagi H
Gan To Kagaku Ryoho; 1997 Jul; 24 Suppl 2():332-6. PubMed ID: 9263525
[TBL] [Abstract][Full Text] [Related]
16. Frequent genetic alterations in EGFR- and HER2-driven pathways in breast cancer brain metastases.
Hohensee I; Lamszus K; Riethdorf S; Meyer-Staeckling S; Glatzel M; Matschke J; Witzel I; Westphal M; Brandt B; Müller V; Pantel K; Wikman H
Am J Pathol; 2013 Jul; 183(1):83-95. PubMed ID: 23665199
[TBL] [Abstract][Full Text] [Related]
17. Prognostic effect of activated EGFR expression in human colon carcinomas: comparison with EGFR status.
Rego RL; Foster NR; Smyrk TC; Le M; O'Connell MJ; Sargent DJ; Windschitl H; Sinicrope FA
Br J Cancer; 2010 Jan; 102(1):165-72. PubMed ID: 19997103
[TBL] [Abstract][Full Text] [Related]
18. BRAF-mutated microsatellite stable colorectal carcinoma: an aggressive adenocarcinoma with reduced CDX2 and increased cytokeratin 7 immunohistochemical expression.
Landau MS; Kuan SF; Chiosea S; Pai RK
Hum Pathol; 2014 Aug; 45(8):1704-12. PubMed ID: 24908142
[TBL] [Abstract][Full Text] [Related]
19. Presence of HER4 associates with increased sensitivity to Herceptin in patients with metastatic breast cancer.
Sassen A; Diermeier-Daucher S; Sieben M; Ortmann O; Hofstaedter F; Schwarz S; Brockhoff G
Breast Cancer Res; 2009; 11(4):R50. PubMed ID: 19624808
[TBL] [Abstract][Full Text] [Related]
20. Molecular alterations and PD-L1 expression in non-ampullary duodenal adenocarcinoma: Associations among clinicopathological, immunophenotypic and molecular features.
Watari J; Mitani S; Ito C; Tozawa K; Tomita T; Oshima T; Fukui H; Kadowaki S; Natsume S; Senda Y; Tajika M; Hara K; Yatabe Y; Shimizu Y; Muro K; Morimoto T; Hirota S; Das KM; Miwa H
Sci Rep; 2019 Jul; 9(1):10526. PubMed ID: 31324814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]